Linsley; Peter S.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Linsley; Peter S..The latest application filed is for "methods of treatment using ctla4 molecules".

Company Profile

4.65.46

Linsley; Peter S. - Seattle WA
Linsley; Peter S. - Encinitas CA US
Linsley; Peter S - Encinitas CA
Linsley; Peter S - Seattle WA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods Of Treatment Using Ctla4 Molecules App 20210115107 - Peach; Robert James ; et al.	2021-04-22
Methods of treatment using CTLA4 mutant molecules Grant 10,370,428 - Peach , et al.	2019-08-06
Methods Of Treatment Using Ctla4 Molecules App 20190185538 - Peach; Robert James ; et al.	2019-06-20
Diagnosis And Prognosis Of Breast Cancer Patients App 20180305768 - Dai; HongYue ; et al.	2018-10-25
Methods Of Treatment Using Ctla4 Mutant Molecules App 20180134764 - PEACH; Robert James ; et al.	2018-05-17
Diagnosis and prognosis of breast cancer patients Grant 9,909,185 - Dai , et al. March 6, 2	2018-03-06
Methods Of Treatment Using Ctla4 Mutant Molecules App 20170369549 - PEACH; Robert James ; et al.	2017-12-28
Methods of treatment using CTLA4 mutant molecules Grant 9,758,565 - Peach , et al. September 12, 2	2017-09-12
Methods and compositions for regulating cell cycle progression Grant 9,200,275 - Linsley , et al. December 1, 2	2015-12-01
Methods Of Treatment Using Ctla4 Mutant Molecules App 20150071914 - PEACH; Robert James ; et al.	2015-03-12
Methods of treatment using CTLA4 mutant molecules Grant 8,785,398 - Peach , et al. July 22, 2	2014-07-22
Methods and compositions for RNA interference Grant 8,609,830 - Jackson , et al. December 17, 2	2013-12-17
Method for selecting SIRNAs from a plurality of SIRNAs for gene silencing Grant 8,457,902 - Jackson , et al. June 4, 2	2013-06-04
Diagnosis And Prognosis Of Breast Cancer Patients App 20130116145 - Dai; HongYue ; et al.	2013-05-09
Methods of using MIR34 as a biomarker for TP53 functional status Grant 8,399,248 - Cleary , et al. March 19, 2	2013-03-19
Compositions comprising MIR34 therapeutic agents for treating cancer Grant 8,378,088 - Cleary , et al. February 19, 2	2013-02-19
Genes Associated With Progression And Response In Chronic Myeloid Leukemia And Uses Thereof App 20120072124 - Radich; Jerald P. ; et al.	2012-03-22
Methods Of Treatment Using Ctla4 Mutant Molecules App 20120052065 - Peach; Robert J. ; et al.	2012-03-01
Diagnosis And Prognosis Of Breast Cancer Patients App 20110301048 - Dai; HongYue ; et al.	2011-12-08
METHOD OF DESIGNING siRNAS FOR GENE SILENCING App 20110250591 - Jackson; Aimee L. ; et al.	2011-10-13
Genes associated with progression and response in chronic myeloid leukemia and uses thereof Grant 8,014,957 - Radich , et al. September 6, 2	2011-09-06
Method of designing siRNAs for gene silencing Grant 7,962,316 - Jackson , et al. June 14, 2	2011-06-14
Methods Of Using Mir34 As A Biomarker For Tp53 Functional Status App 20110105583 - Cleary; Michele A. ; et al.	2011-05-05
Expression vectors encoding bispecific fusion proteins and methods of producing biologically active bispecific fusion proteins in a mammalian cell Grant 7,915,395 - Ledbetter , et al. March 29, 2	2011-03-29
Diagnosis and prognosis of breast cancer patients Grant 7,863,001 - Dai , et al. January 4, 2	2011-01-04
Methods for protecting allogeneic islet transplant using soluble CTLA4 mutant molecules Grant 7,829,534 - Larsen , et al. November 9, 2	2010-11-09
Compositions Comprising Mir34 Therapeutic Agents For Treating Cancer App 20100227909 - Cleary; Michele A. ; et al.	2010-09-09
Methods Of Treatment Using Ctla4 Mutant Molecules App 20100183612 - Peach; Robert J. ; et al.	2010-07-22
Methods of treatment using CTLA4 mutant molecules Grant 7,700,556 - Peach , et al. April 20, 2	2010-04-20
Methods And Compositions For Regulating Cell Cycle Progression App 20100035966 - Linsley; Peter S. ; et al.	2010-02-11
Soluble CTLA4 mutant molecules and uses thereof App 20090317397 - Linsley; Peter S. ; et al.	2009-12-24
Modified polynucleotides for reducing off-target effects in RNA interference Grant 7,595,387 - Leake , et al. September 29, 2	2009-09-29
Soluble CTLA4 mutant molecules Grant 7,572,772 - Linsley , et al. August 11, 2	2009-08-11
Methods For Inhibiting An Immune Response By Blocking The Gp39/cd40 And Ctla4/cd28/b7 Pathways And Compositions For Use Therewith App 20090186037 - Larsen; Christian P. ; et al.	2009-07-23
Diagnosis and prognosis of breast cancer patients App 20090157326 - Dai; HongYue ; et al.	2009-06-18
Methods and compositions for regulating cell cycle progression via the miR-106B family App 20090136957 - Ivanovska; Irena ; et al.	2009-05-28
Diagnosis and prognosis of breast cancer patients Grant 7,514,209 - Dai , et al. April 7, 2	2009-04-07
Methods of treatment using CTLA4 mutant molecules App 20090041769 - Peach; Robert J. ; et al.	2009-02-12
Methods for treating immune system diseases using a soluble CTLA4 molecule Grant 7,455,835 - Cohen , et al. November 25, 2	2008-11-25
Methods of treatment using CTLA4 mutant molecules Grant 7,439,230 - Peach , et al. October 21, 2	2008-10-21
Method of Designing Sirnas for Gene Silencing App 20080234941 - Jackson; Aimee L. ; et al.	2008-09-25
Methods for protecting allogeneic islet transplant using soluble CTLA4 mutant molecules App 20080160022 - Larsen; Christian P. ; et al.	2008-07-03
CTLA4 molecules and IL4-binding molecules and uses thereof App 20080031876 - Linsley; Peter S. ; et al.	2008-02-07
Methods for treating cancer and infectious disease by blocking CTLA4-B7 interactions Grant 7,311,910 - Linsley , et al. December 25, 2	2007-12-25
Methods for protecting allogeneic islet transplant using soluble CTLA4 mutant molecules Grant 7,304,033 - Larsen , et al. December 4, 2	2007-12-04
Genes associate with progression and response in chronic myeloid leukemia and uses thereof App 20070154931 - Radich; Jerald P. ; et al.	2007-07-05
Methods and compositions for rna interference App 20070149468 - Jackson; Aimee L. ; et al.	2007-06-28
Methods for identifying modulators of kinesin activity App 20070134660 - Mao; Mao ; et al.	2007-06-14
Methods of assigning treatment to breast cancer patients Grant 7,171,311 - Dai , et al. January 30, 2	2007-01-30
Signature genes in chronic myelogenous leukemia App 20060292623 - Linsley; Peter S. ; et al.	2006-12-28
Soluble CTLA4 mutant molecules and uses thereof Grant 7,105,166 - Linsley , et al. September 12, 2	2006-09-12
Soluble CTLA4 mutant molecules Grant 7,094,874 - Peach , et al. August 22, 2	2006-08-22
Methods for blocking binding of CD28 receptor to B7 Grant 7,070,776 - Linsley , et al. July 4, 2	2006-07-04
Iterative probe design and detailed expression profiling with flexible in-situ synthesis arrays App 20060141501 - Friend; Stephen H. ; et al.	2006-06-29
Method of inhibiting immune system destruction of transplanted viable cells Grant 7,041,634 - Weber , et al. May 9, 2	2006-05-09
Iterative probe design and detailed expression profiling with flexible in-situ synthesis arrays Grant 7,013,221 - Friend , et al. March 14, 2	2006-03-14
Soluble CTLA4 mutant molecules and uses thereof App 20050214313 - Peach, Robert J. ; et al.	2005-09-29
Methods for inhibiting an immune response by blocking the GP39/CD40 and CTLA4/CD28/B7 pathways and compositions for use therewith App 20050202011 - Larsen, Christian P. ; et al.	2005-09-15
Synthetic lethal screen using RNA interference App 20050181385 - Linsley, Peter S. ; et al.	2005-08-18
CTLA4 molecules and IL4-binding molecules and uses thereof App 20050169919 - Linsley, Peter S. ; et al.	2005-08-04
Method to inhibit T cell interactions with soluble B7 Grant 6,887,471 - Linsley , et al. May 3, 2	2005-05-03
Method for generating and identifying antibodies directed against a B7 Grant 6,830,937 - Linsley , et al. December 14, 2	2004-12-14
Diagnosis and prognosis of breast cancer patients App 20040058340 - Dai, HongYue ; et al.	2004-03-25
Method Of Inhibiting Immune System Destruction Of Transplanted Viable Cells App 20040047890 - WEBER, COLLIN J. ; et al.	2004-03-11
LXR-ligand induced genes and proteins App 20040023276 - Ward, Teresa R. ; et al.	2004-02-05
Soluble CTLA4 mutant molecules and uses thereof App 20040014171 - Peach, Robert James ; et al.	2004-01-22
Diagnosis and prognosis of breast cancer patients App 20030224374 - Dai, HongYue ; et al.	2003-12-04
Ligand for CD28 receptor on B cells and methods App 20030219446 - Linsley, Peter S. ; et al.	2003-11-27
Soluble CTLA4 mutant molecules and uses thereof App 20030219863 - Peach, Robert J. ; et al.	2003-11-27
Expression vectors encoding bispecific fusion proteins and methods of producing biologically active bispecific fusion proteins in a mammalian cell App 20030219876 - Ledbetter, Jeffrey A. ; et al.	2003-11-27
Method of regulating cellular processes mediated by B7 and CD28 Grant 6,641,809 - Linsley , et al. November 4, 2	2003-11-04
Expression vectors encoding bispecific fusion proteins and methods of producing biologically active bispecific fusion proteins in a mammalian cell Grant 6,623,940 - Ledbetter , et al. September 23, 2	2003-09-23
Genes and proteins associated with T cell activation App 20030119024 - Linsley, Peter S. ; et al.	2003-06-26
Signature genes in chronic myelogenous leukemia App 20030104426 - Linsley, Peter S. ; et al.	2003-06-05
Soluble Ctla4 Mutant Molecules And Uses Thereof App 20030035816 - PEACH, ROBERT JAMES ; et al.	2003-02-20
Soluble CTLA4 mutant molecules and uses thereof App 20020182211 - Peach, Robert J. ; et al.	2002-12-05
Expression vectors encoding bispecific fusion proteins and methods of producing biologically active bispecific fusion proteins in a mammalian cell Grant 6,482,919 - Ledbetter , et al. November 19, 2	2002-11-19
Methods for inhibiting the production of HIV-1 retrovirus using monoclonal antibodies and Fv specific for CD2 antigen Grant 6,384,198 - Diegel , et al. May 7, 2	2002-05-07
Methods for inhibiting an immune response by blocking the GP39/CD40 and CTLA4/CD28/B7 pathways and compositions for use therewith App 20020031510 - Larsen, Christian P. ; et al.	2002-03-14
Expression vectors encoding bispecific fusion proteins and methods of producing biologically active bispecific fusion proteins in a mammalian cell App 20020012989 - Ledbetter, Jeffrey A. ; et al.	2002-01-31
RNA amplification method Grant 6,271,002 - Linsley , et al. August 7, 2	2001-08-07
Expression vectors encoding bispecific fusion proteins and methods of producing biologically active bispecific fusion proteins in a mammalian cell Grant 6,132,992 - Ledbetter , et al. October 17, 2	2000-10-17
CTLA4/CD28Ig hybrid fusion proteins and uses thereof Grant 6,090,914 - Linsley , et al. July 18, 2	2000-07-18
Methods for prolonging the expression of a heterologous gene of interest using soluble CTLA4 molecules and an antiCD40 ligand Grant 5,993,800 - Linsley , et al. November 30, 1	1999-11-30
CTLA4 receptor and uses thereof Grant 5,977,318 - Linsley , et al. November 2, 1	1999-11-02
CTLA4 receptor and uses thereof Grant 5,968,510 - Linsley , et al. October 19, 1	1999-10-19
Methods for inhibiting an immune response by blocking the GP39/CD40 and CTLA4/CD28/B7 pathways and compositions for use therewith Grant 5,916,560 - Larsen , et al. June 29, 1	1999-06-29
Anti-oncostatin M monoclonal antibodies Grant 5,907,033 - Radka , et al. May 25, 1	1999-05-25
CTLA4 receptor and uses thereof Grant 5,885,579 - Linsley , et al. March 23, 1	1999-03-23
CTLA4 receptor and uses thereof Grant 5,885,796 - Linsley , et al. March 23, 1	1999-03-23
Soluble CTLA4 molecules and uses thereof Grant 5,851,795 - Linsley , et al. December 22, 1	1998-12-22
Hybridomas producing monoclonal antibodies to new mucin epitopes Grant 5,849,876 - Linsley , et al. December 15, 1	1998-12-15
CTLA4 Ig fusion proteins Grant 5,844,095 - Linsley , et al. December 1, 1	1998-12-01
Monoclonal antibodies and FV specific for CD2 antigen Grant 5,807,734 - Diegel , et al. September 15, 1	1998-09-15
Monoclonal antibodies and FV specific for CD2 antigen Grant 5,795,572 - Diegel , et al. August 18, 1	1998-08-18
MYPPPY variants of CTL A4 and uses thereof Grant 5,773,253 - Linsley , et al. June 30, 1	1998-06-30
Methods for regulating the immune response using B7 binding molecules and IL4-binding molecules Grant 5,770,197 - Linsley , et al. June 23, 1	1998-06-23
Mixed specificity fusion proteins Grant 5,709,859 - Aruffo , et al. January 20, 1	1998-01-20
Expression vectors encoding bispecific fusion proteins and methods of producing biologically active bispecific fusion proteins in a mammalian cell Grant 5,637,481 - Ledbetter , et al. June 10, 1	1997-06-10
Oncostatin M and novel compositions having anti-neoplastic activity Grant 5,618,715 - Shoyab , et al. April 8, 1	1997-04-08
B7IG fusion protein Grant 5,580,756 - Linsley , et al. December 3, 1	1996-12-03
CD28IG fusion protein Grant 5,521,288 - Linsley , et al. May 28, 1	1996-05-28
Oncostatin M and novel compositions having anti-neoplastic activity Grant 5,451,506 - Shoyab , et al. September 19, 1	1995-09-19
Chimeric CTLA4 receptor and methods for its use Grant 5,434,131 - Linsley , et al. July 18, 1	1995-07-18
Assay for human breast cancer Grant 4,803,169 - Linsley , et al. February 7, 1	1989-02-07

Company Registrations

SEC

0001517032

LINSLEY PETER S

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.